Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Genetic Test Predicts Obesity in Childhood

By LabMedica International staff writers
Posted on 22 Jul 2025

Obesity is a rapidly growing global health issue, with the World Obesity Federation projecting that more than half the world's population will be overweight or obese by 2035. More...

Current treatment options such as lifestyle changes, surgery, and medication are not universally effective or accessible. Moreover, identifying individuals at high risk early enough to prevent the onset of obesity remains a major challenge. Subtle variations in our genomes play a role in increasing susceptibility to obesity, especially through mechanisms like appetite regulation in the brain. Early identification of genetic risk before physical symptoms develop could help enable preventive strategies. Now, a new genetic approach offers the ability to identify children at high risk for obesity well before their weight is affected, potentially opening the door to earlier and more effective interventions.

Researchers from the University of Copenhagen (Copenhagen, Denmark) and the University of Bristol (Bristol, UK) have developed a new polygenic score (PGS) to predict obesity risk. The PGS was created using the genetic data of over five million people, the largest and most diverse dataset of its kind. The score aggregates the effects of thousands of individual genetic variants linked to obesity and calculates an overall risk value for each person. The researchers tested the PGS using data from more than 500,000 individuals and explored its predictive power through the lens of both physical traits and genetic profiles. They also examined how heart health indicators like BMI, sex, and hypertension influence risk. The work draws on contributions from over 600 scientists across 500 institutions globally, as part of a broader effort to understand anthropometric traits such as BMI and height.

The PGS was found to be twice as effective as previous best-in-class tests for predicting obesity risk. It was also particularly effective in identifying genetic risk in early childhood, even before the age of five. The findings, published in Nature Medicine, show that individuals with higher genetic risk scores responded more strongly to lifestyle-based weight loss interventions like diet and exercise but they also tended to regain weight more quickly once those interventions stopped. However, a key limitation remains: the PGS was significantly more accurate in people of European ancestry than those of African ancestry, despite the use of a more globally representative genetic dataset. Moving forward, the researchers aim to refine the model to improve its predictive power across more diverse populations and continue exploring its use in early prevention strategies.

"This new polygenic score is a dramatic improvement in predictive power and a leap forward in the genetic prediction of obesity risk, which brings us much closer to clinically useful genetic testing," said Professor Ruth Loos, senior author of the study.


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.